Lifecore Biomedical
Open
$5.64
Prev. Close
$5.64
High
$5.66
Low
$5.64
Market Snapshot
$211.37M
-4.9
-0.51
$130.86M
400
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. The company is headquartered in Chaska, Minnesota and currently employs 382 full-time employees. The company manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. The company manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. The company also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. The company is headquartered in Chaska, Minnesota and currently employs 382 full-time employees. The company manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) using fermentation-based HA process. The company manufactures HA in bulk form and for use in formulated and filled syringes and vials for our customers’ injectable products used in treating medical conditions and procedures, including ophthalmic and orthopedic applications. Its product development service capabilities include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation and production of materials for clinical studies. The company also operates semi-automated restricted access barrier systems (RABS) and fully automated aseptic filling lines with isolators.
Recently from Cashu
Lifecore Biomedical Reports 9.8% Revenue Growth in Fourth Quarter, Meeting Analyst Expectations
Lifecore Biomedical Reports Strong Fourth-Quarter Revenue Growth Lifecore Biomedical delivers encouraging news in its latest fourth-quarter financial report, revealing a revenue of $35.7 million for t…
Lifecore Biomedical Reports 9.8% Revenue Growth in Strong Fourth Quarter Performance
Lifecore Biomedical’s Fourth-Quarter Performance Illustrates Ongoing Growth Lifecore Biomedical’s recent fourth-quarter report reveals a noteworthy achievement, as the company records a revenue of $35…
Lifecore Biomedical Reports 9.8% Revenue Growth in Fourth Quarter Amid Market Competition
Lifecore Biomedical's Fourth-Quarter Performance Reflects Steady Growth Amid Competitive Landscape In its recent fourth-quarter report, Lifecore Biomedical reveals a revenue of $35.7 million, marking…
Lifecore Biomedical Posts 9.8% Revenue Growth in Strong Fourth Quarter Performance
Lifecore Biomedical Reports Strong Fourth-Quarter Performance Lifecore Biomedical has recently announced its fourth-quarter earnings, reporting a revenue of $35.7 million, a notable year-over-year inc…